Also sold as: Benemid, Probecid, Probenecid BP
Pregnancy
Cat B
Lactation
Unknown
Schedule
H
Forms
Tablets 500 mg
Chronic gout — hyperuricaemia (initiation)
250 mg orally twice daily for 1 week
Then increase to 500 mg twice daily; may increase by 500 mg/month to maximum 2 g/day (in 2–4 divided doses)
CRITICAL: Do NOT start probenecid during an acute gout attack — will worsen acute attack. Wait for full resolution. Maintain high fluid intake (at least 2 L/day) to prevent uric acid nephrolithiasis (probenecid increases urinary uric acid excretion). Add colchicine prophylaxis for 3–6 months on initiation to prevent mobilisation flares. Monitor serum uric acid; target <6 mg/dL.
Adjunct to penicillin/ampicillin/cephalosporins
500 mg orally four times daily (2 g/day)
Taken concurrently with the antibiotic course
Probenecid blocks OAT-mediated renal tubular secretion of penicillins and cephalosporins — extends antibiotic half-life and raises plasma levels. Used in penicillin-scarce settings, gonorrhoea treatment (500 mg QID + ampicillin 3.5 g stat), and to extend cefixime/ceftriaxone levels in Lyme disease.
| CrCl / eGFR | Dose Adjustment |
|---|---|
| CrCl <30 mL/min | Avoid — probenecid acts by blocking urate secretion in the renal proximal tubule; inadequate GFR means insufficient uric acid is filtered to allow effective uricosuric action. Use allopurinol or febuxostat in CKD patients. |
| CrCl ≥30 mL/min | Use with caution; probenecid is ineffective as a uricosuric when GFR is significantly reduced |
No specific dose adjustment; use with caution in severe hepatic disease — limited data.
Pregnancy: Category B
Animal studies show no teratogenicity. Limited human data but widely used as an antibiotic adjunct during pregnancy without evidence of harm. Gout in pregnancy is uncommon; risks of untreated gout (dehydration, pain) should be weighed against theoretical risks. Short-term use for antibiotic augmentation is generally considered acceptable.
Lactation: Unknown
No data on breast milk excretion in humans. Use with caution during lactation; monitor infant if use is necessary.
| Interacting Drug | Effect | Severity |
|---|---|---|
| Penicillins, ampicillin, amoxicillin, and cephalosporins | Intentional major pharmacokinetic interaction — probenecid blocks OAT-mediated renal tubular secretion of these antibiotics, significantly increasing their plasma levels (2–3 fold) and prolonging half-life. Used clinically to extend antibiotic coverage. Monitor for antibiotic toxicity at high doses | Major |
| Methotrexate (MTX) | Probenecid blocks renal tubular secretion of methotrexate — markedly increases MTX plasma levels and risk of toxicity (bone marrow suppression, mucositis, hepatotoxicity, nephrotoxicity). Combination requires MTX dose reduction and close monitoring; generally avoid | Major |
| Salicylates (aspirin) — even low-dose aspirin | Salicylates at low doses retain uric acid (compete with urate at OAT) and antagonise the uricosuric effect of probenecid; at high doses, aspirin is weakly uricosuric. Avoid concurrent low-dose aspirin with probenecid if possible; use acetaminophen/paracetamol for analgesia instead | Moderate |
| Dapsone | Probenecid blocks renal tubular secretion of dapsone and its metabolites — increases dapsone plasma levels; risk of methaemoglobinaemia and haematological toxicity | Moderate |
| Rifampicin | Probenecid blocks hepatic uptake and biliary excretion of rifampicin — increases rifampicin plasma levels; monitor for rifampicin-related hepatotoxicity | Moderate |
DoctorScribe — AI Medical Scribe
"Probenecid as per dose, BD for 5 days." DoctorScribe writes the full prescription with brand, strength, frequency, and route — auto-applies pediatric weight-based dosing and renal adjustments. Try the live demo.
Common
Serious / Discontinue If
| Brand | Manufacturer | Price (approx) |
|---|---|---|
| Benemid 500 mg Tablets | Various manufacturers | ₹35/10 tablets |
| Probenecid BP 500 mg Tablets | Various manufacturers | ₹28/10 tablets |
EasyClinic auto-flags Probenecid interactions, renal cutoffs, and pregnancy warnings the moment you write the prescription. Built-in safety net for every Indian doctor.
Clinically reviewed by: Dr. Sanjay Kulkarni, MD (Medicine), DM (Clinical Immunology & Rheumatology)
Last reviewed: 2026-04-15